ZA979390B - Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses. - Google Patents

Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.

Info

Publication number
ZA979390B
ZA979390B ZA9709390A ZA979390A ZA979390B ZA 979390 B ZA979390 B ZA 979390B ZA 9709390 A ZA9709390 A ZA 9709390A ZA 979390 A ZA979390 A ZA 979390A ZA 979390 B ZA979390 B ZA 979390B
Authority
ZA
South Africa
Prior art keywords
repression
polypeptides
transcription
domains
proteins
Prior art date
Application number
ZA9709390A
Other languages
English (en)
Inventor
Abderrahim Mahfoudi
Alain Fournier
Christophe Marcireau
Didier Branellec
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA979390B publication Critical patent/ZA979390B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/788Of specified organic or carbon-based composition
    • Y10S977/797Lipid particle
    • Y10S977/798Lipid particle having internalized material
    • Y10S977/799Containing biological material
    • Y10S977/80Nucleic acid, e.g. DNA or RNA
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA9709390A 1996-10-18 1997-10-20 Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses. ZA979390B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612730A FR2754822B1 (fr) 1996-10-18 1996-10-18 Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations

Publications (1)

Publication Number Publication Date
ZA979390B true ZA979390B (en) 1998-05-12

Family

ID=9496803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709390A ZA979390B (en) 1996-10-18 1997-10-20 Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.

Country Status (22)

Country Link
US (1) US6121005A (ru)
EP (1) EP0941243A1 (ru)
JP (1) JP2001503615A (ru)
KR (1) KR20000049249A (ru)
CN (1) CN1237980A (ru)
AP (1) AP9901510A0 (ru)
AU (1) AU741586B2 (ru)
BG (1) BG63548B1 (ru)
BR (1) BR9711947A (ru)
CA (1) CA2268045A1 (ru)
CZ (1) CZ131899A3 (ru)
EA (1) EA003694B1 (ru)
FR (1) FR2754822B1 (ru)
HU (1) HUP9903956A3 (ru)
IL (1) IL129478A0 (ru)
NO (1) NO991830L (ru)
NZ (1) NZ335283A (ru)
OA (1) OA11034A (ru)
PL (1) PL332874A1 (ru)
SK (1) SK51199A3 (ru)
WO (1) WO1998017686A1 (ru)
ZA (1) ZA979390B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000241A2 (en) * 2000-06-28 2002-01-03 Aventis Pharma S.A. Compositions and methods for regulating the cell cycle using a ki gene or polypeptide
US8124598B2 (en) 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20130059773A1 (en) * 2010-02-24 2013-03-07 Veronique Witko-Sarsat Compounds for the treatment of inflammation and neutropenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
GB9422175D0 (en) * 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
FR2732357B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose
FR2740344B1 (fr) * 1995-10-31 1997-11-21 Rhone Poulenc Rorer Sa Application de la proteine gax au traitement de cancers

Also Published As

Publication number Publication date
EA003694B1 (ru) 2003-08-28
AU741586B2 (en) 2001-12-06
PL332874A1 (en) 1999-10-25
NO991830D0 (no) 1999-04-16
SK51199A3 (en) 2000-04-10
EP0941243A1 (fr) 1999-09-15
CN1237980A (zh) 1999-12-08
CA2268045A1 (fr) 1998-04-30
FR2754822B1 (fr) 1998-11-27
BG63548B1 (bg) 2002-04-30
WO1998017686A1 (fr) 1998-04-30
BR9711947A (pt) 1999-08-24
FR2754822A1 (fr) 1998-04-24
AU4871397A (en) 1998-05-15
KR20000049249A (ko) 2000-07-25
US6121005A (en) 2000-09-19
HUP9903956A2 (hu) 2000-03-28
CZ131899A3 (cs) 1999-07-14
JP2001503615A (ja) 2001-03-21
IL129478A0 (en) 2000-02-29
BG103342A (en) 2000-05-31
NO991830L (no) 1999-06-16
NZ335283A (en) 2001-02-23
AP9901510A0 (en) 1999-06-30
EA199900387A1 (ru) 1999-10-28
HUP9903956A3 (en) 2002-01-28
OA11034A (fr) 2003-03-06

Similar Documents

Publication Publication Date Title
PT1490386E (pt) Novos polipéptidos e ácidos nucleicos que os codificam
PT2233498E (pt) Proteínas de inibição de calicreína de domínio kunitz e ácidos nucleicos que as codificam
IL197834A0 (en) Polypeptides and nucleic acids encoding the same
EP0681585A4 (en) FACTORS ASSOCIATED TO TATA-BINDING PROTEINS, NUCLEIC ACIDS ENCODING TAFS AND METHODS FOR USE THEREOF.
WO1998021343A8 (en) Genes encoding telomerase proteins
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
EP1001964A4 (en) TANGO-78, TANGO-79 AND TANGO-81 NUCLEIC ACID MOLECULES
ID24914A (id) Protein-protein pengikat peptida b-amiloid dan polinukleotida yang menuliskan kode protein tersebut
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
ZA979390B (en) Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
AU2002304163A1 (en) Polypeptide unstabilizing protein in cells under aerobic conditions and DNA encoding the same
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
ZA918423B (en) Proteins and nucleic acids.
EP1071749A4 (en) NUCLEIC ACID AND LRSG PROTEIN MOLECULES AND USES THEREOF
EP0677115A4 (en) TIA-1 FIXING PROTEINS AND ISOLATED COMPLEMENTARY DNA ENCODING THEM.
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
AU1290499A (en) Actin-binding polypeptides and nucleic acids encoding the same
AU5137698A (en) Novel dna, novel protein, and novel antibody
AU1525499A (en) Ikap proteins, nucleic acids and methods
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
ZA988460B (en) Polypeptides and nucleic acids encoding the same
IL122626A0 (en) Nucleic acids encoding hev structural proteins hev structural proteins encoded thereby and uses thereof